Printer Friendly

Reportlinker Adds Opportunities and Key Players in Clinical Nutrition: the Market for Enteral, Parenteral and Infant Nutrition in The US And The EU.

NEW YORK -- announces that a new market research report is available in its catalogue.

Reportlinker Adds Opportunities and Key Players in Clinical Nutrition: The market for enteral, parenteral and infant nutrition in the US and the EU

Opportunities and Key Players in Clinical Nutrition

The market for enteral, parenteral and infant nutrition in the US and the EU

Report Overview

In both the US and EU, the clinical nutrition industry is undergoing a significant shift as major players re-align their businesses. While some are divesting clinical nutrition operations to focus on prescription medicines, others are building their capabilities to expand their presence in clinical nutrition. This is resulting in some players, such as Novartis, exiting the market while others, like Nestle, are growing. Demand for clinical nutrition products continues to rise with aging populations that are using more health care products and services, as well as a rising rate of premature births that is fueling increases in infant clinical nutrition. Rising demand, coupled with the introduction of sophisticated new clinical nutrition products, will support market growth over the next five years.

'Opportunities and Key Players in Clinical Nutrition: The market for enteral, parenteral and infant nutrition in the US and the EU' is a new nutrition report published by Business Insights report that provides an in-depth analysis of the clinical nutrition industry within the US and EU, including sales forecasts from 2008 to 2013. It offers a detailed breakdown of the products, positions and market shares of the leading manufacturers of clinical nutrition products, as well as a discussion of other important players such as ingredient suppliers and service providers. This report defines clinical nutrition as nutritional products used under the supervision (but not necessarily prescription) of a physician in accordance with the US Orphan Drug Act; therefore, forecasts may differ from some other nutrition product estimates.

Key Findings

Parenteral nutrition will demonstrate the strongest growth, at 11.3% per year, on average, followed by enteral nutrition with 7.4% annual growth and infant nutrition with 7.0%.

In the United States, approximately 465,000 persons relied upon clinical nutrition in 2008. Over the next 5 years, this group will expand by 8.7% per year, with the greatest growth in the parenteral segment (11.3% annually) followed by enteral tube feeding (8.9% per year).

In the EU, more than 650,000 individuals utilized clinical nutrition in 2008. Through 2013, the total number of European clinical nutrition patients will expand by 7.7% per year.

No single company represents more than about 20% of the market, as few have expertise in both the US and EU regions for all three clinical nutrition segments.

Use this report to...

* Understand the latest trends and developments in clinical nutrition patient populations and identify the products and ingredients associated with each term of treatment.

* Quantify future growth areas in the clinical nutrition market based on this report's analysis and forecasts of the clinical nutrition market by region (US, EU) and segment (enteral, parenteral, infant) from 2008-2013.

* Identify the drivers and key issues that are shaping the clinical nutrition segment across the EU and the US and how they will impact product formulation and marketing in 2009 and beyond.

* Benchmark your competitive position aganist other players in the clinical nutrition market using this report's analysis of the performance of key players including Abbott Clinical Nutrition, B. Braun Medical, Baxter, Danone Baby and Medical Nutrition, Fresenius Kabi, Hospira, Mead Johnson, Nestle HealthCare Nutrition & Wyeth.

Key issues...

Consolidation. The clinical nutrition industry is undergoing consolidation as major players either divest or acquire operations. This will result in heightened competition as the market whittles down to those companies most determined to carve out leading positions.

New Product Development. The makers of parenteral therapies are introducing sophisticated new clinical nutrition products that will replace many of the older, less cutting edge products.

Aging Population. Demand for products is rising strongly with aging populations in the US and EU as well as rising rates of premature birth in both regions.

Homecare. Increasing utilization of home care is expanding the usage of clinical nutrition in the home, driving demand for products that are simple to use.

Your questions answered

* Why is the clinical nutrition market growing so quickly?

* Which segment of the clinical nutrition market will experience the strongest growth?

* What patient population will drive the greatest market growth?

* Which diseases account for the greatest proportion of clinical nutrition patients?

* What characteristic do the most successful clinical nutrition companies share?

* Which type of companies will gain market share over the next 5 years?

Executive summary 10

Introduction 10

Clinical nutrition in the US 11

Clinical nutrition in the EU 12

Major players in clinical nutrition 13

Chapter 1 Introduction 16

Summary 16

Summary 17

Background 17

Patient populations 18

Cancer patients 20

Clinical nutrition for cancer patients 22

Gastrointestinal disease patients 24

Clinical nutrition for GI disease patients 25

Other clinical nutrition patients 28

AIDS patients 28

Anorexia nervosa patients 29

Burn patients 30

Environments for clinical nutrition 31

Inpatient environments 31

Outpatient environments 32

Major types of clinical nutrition 34

Enteral nutrition 36

Products and ingredients 39

Parenteral nutrition 42

Products and ingredients 44

Infant nutrition 45

Products and ingredients 47

Ingredients 50

Related products 51

Market summary 52

Chapter 2 Clinical nutrition in the US 56

Summary 56

Introduction 57

Regulation 57

Insurance reimbursement 61

User populations 63

Enteral nutrition 64

Key products and players 64

Sales and market share 66

Sales structure and channels 67

New product development 68

Issues and trends 69

Parenteral nutrition 71

Key products and players 71

Sales and market share 72

Sales structure and channels 74

New product development 75

Issues and trends 75

Infant nutrition 76

Key products and players 77

Sales and market share 77

Sales structure and channels 79

New product development 79

Issues and trends 80

Conclusions 80

Chapter 3 Clinical nutrition in Europe 82

Summary 82

Introduction 83

Regulation 83

Insurance reimbursement 84

User populations 84

Market heterogeneity 86

Enteral nutrition 88

Key products and players 88

Sales and market share 89

Sales structure and channels 91

New product development 91

Issues and trends 92

Parenteral nutrition 93

Key products and players 93

Sales and market share 94

Sales structure and channels 96

New product development 96

Issues and trends 97

Infant nutrition 99

Key products and players 99

Sales and market share 100

Sales structure and channels 102

New product development 102

Issues and trends 103

Chapter 4 Major players in clinical nutrition 106

Summary 106

Introduction 107

Leading suppliers of clinical nutrition 108

Current market share 108

Company profiles 110

Abbott Clinical Nutrition 110

B. Braun Medical 111

Baxter 113

Danone Baby and Medical Nutrition 114

Fresenius Kabi 115

Hospira 116

Mead Johnson 116

Nestle HealthCare Nutrition 118

Wyeth 119

Other important market participants 120

Company profiles 120

Ajinomoto 120

Alaris Medical Systems/Cardinal Health 120

American HomePatient 121

Apria Healthcare 121

Arrow International/Teleflex 121

DSM 122

Gentiva Health Services 122

Kyowa Hakko 123

Lonza 123

Martek 123

Index 125

List of Figures

Figure 1.1: Total US and EU markets for clinical nutrition ($m), 2008 52

Figure 1.2: Clinical nutrition forecast market growth by region ($m), 2008 - 2013 53

Figure 1.3: Clinical nutrition forecast market growth by segment ($m), 2008 - 2013 54

Figure 2.4: Forecast number of US clinical nutrition patients ($m), 2008 - 2013 63

Figure 2.5: Forecast US enteral nutrition market ($), 2008 - 2013 66

Figure 2.6: Market share of leading US enteral nutrition players (%), 2008 67

Figure 2.7: Market share of leading players in the US parenteral nutrition market (%), 2008 - 2013 73

Figure 2.8: Sales of leading US parenteral nutrition players ($m), 2008 74

Figure 2.9: Forecast US infant nutrition market ($m), 2008 - 2013 78

Figure 2.10: Market share of leading US infant nutrition players (%), 2008 79

Figure 3.11: Forecast number of EU clinical nutrition patients ('000), 2008 - 2013 85

Figure 3.12: Forecast EU enteral nutrition market ($m), 2008 - 2013 90

Figure 3.13: Market share of leading EU enteral nutrition players (%), 2008 91

Figure 3.14: Forecast EU parenteral nutrition market ($m), 2008 - 2013 95

Figure 3.15: Sales of leading EU parenteral nutrition players ($m), 2008 96

Figure 3.16: Forecast EU infant nutrition market ($m), 2008 - 2013 101

Figure 3.17: Market share of leading EU infant nutrition players (%), 2008 102

Figure 4.18: Market share of leading clinical nutrition manufacturers (%), 2008 108

Figure 4.19: Projected market shares of leading clinical nutrition manufacturers (%), 2013 110

List of Tables

Table 1.1: Nutritive needs by condition 19

Table 1.2: Patients using medical nutrition by condition and type of supplementation, 2009 20

Table 1.3: Inpatient care facilities in the US and EU, 2009 32

Table 1.4: Indications and contraindications for enteral feeding and TPN 35

Table 1.5: Disease specific enteral nutrition products 41

Table 1.6: Advantages and disadvantages of parenteral nutrition 42

Table 1.7: Composition of neonatal venous nutrient solutions (per liter) 49

Table 2.8: Medicare reimbursement for enteral nutrition products, 2009 62

Table 2.9: Leading US enteral nutrition products, 2009 65

Table 2.10: US parenteral nutrition products, 2009 72

Table 2.11: Leading US infant nutrition products, 2009 76

Table 3.12: Demographic and healthcare data for EU member countries, 2006 87

Table 3.13: Leading EU enteral nutrition products, 2009 89

Table 3.14: Leading EU parenteral nutrition products, 2009 94

Table 3.15: ESPEN guidelines for parenteral nutrition in ICU patients, 2008 98

Table 3.16: Leading EU infant nutrition products, 2009 100

Table 4.17: Estimated sales of leading clinical nutrition players 109

Table 4.18: Abbott Nutrition: market position, 2008 111

Table 4.19: B. Braun: market position, 2008 113

Table 4.20: Baxter: market position, 2008 114

Table 4.21: Danone Baby and Medical Nutrition: market position, 2008 115

Table 4.22: Fresenius Kabi: market position, 2008 116

Table 4.23: Mead Johnson: market position, 2008 117

Table 4.24: Nestle: market position, 2008 119

To order this report:

Reportlinker Adds Opportunities and Key Players in Clinical Nutrition: The market for enteral, parenteral and infant nutrition in the US and the EU

More market research reports here!
COPYRIGHT 2009 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 26, 2009
Previous Article:Research and Markets: The Taiwanese Small and Medium Size TFT LCD Panel Industry, 2Q 2009 - Order Now.
Next Article:Reportlinker Adds Asthma and COPD Market Forecast.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters